NO312729B1 - Imidazopyridaziner - Google Patents
Imidazopyridaziner Download PDFInfo
- Publication number
- NO312729B1 NO312729B1 NO19993050A NO993050A NO312729B1 NO 312729 B1 NO312729 B1 NO 312729B1 NO 19993050 A NO19993050 A NO 19993050A NO 993050 A NO993050 A NO 993050A NO 312729 B1 NO312729 B1 NO 312729B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- sulfur
- oxygen
- mmol
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 107
- -1 hexopyranoses Chemical compound 0.000 claims description 70
- 150000003839 salts Chemical class 0.000 claims description 42
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 36
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 36
- 229910052760 oxygen Inorganic materials 0.000 claims description 36
- 239000001301 oxygen Substances 0.000 claims description 36
- 239000001257 hydrogen Substances 0.000 claims description 32
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 32
- 229910052717 sulfur Inorganic materials 0.000 claims description 32
- 239000011593 sulfur Substances 0.000 claims description 31
- 150000002431 hydrogen Chemical class 0.000 claims description 30
- 150000001204 N-oxides Chemical class 0.000 claims description 24
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 125000004076 pyridyl group Chemical group 0.000 claims description 16
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 11
- 125000002619 bicyclic group Chemical group 0.000 claims description 10
- 125000004122 cyclic group Chemical group 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims description 8
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 8
- 150000003536 tetrazoles Chemical class 0.000 claims description 8
- 125000000335 thiazolyl group Chemical group 0.000 claims description 8
- 241000589989 Helicobacter Species 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 93
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 78
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 61
- 239000000243 solution Substances 0.000 description 57
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 34
- 239000007787 solid Substances 0.000 description 34
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- 239000000725 suspension Substances 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000002244 precipitate Substances 0.000 description 23
- 238000001816 cooling Methods 0.000 description 18
- 239000000284 extract Substances 0.000 description 18
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 17
- 235000019341 magnesium sulphate Nutrition 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- PBRVBSFCOONPOY-UHFFFAOYSA-N 6-[3-[2-(chloromethyl)-3-methylpyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine Chemical compound C1=CN=C(CCl)C(C)=C1SCCCSC1=NN2C([N+]([O-])=O)=CN=C2C=C1 PBRVBSFCOONPOY-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000012043 crude product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 7
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- NEKMBLKAKOUTAX-UHFFFAOYSA-N 3-nitro-5h-imidazo[1,2-b]pyridazine-6-thione Chemical compound C1=CC(=S)NN2C([N+](=O)[O-])=CN=C21 NEKMBLKAKOUTAX-UHFFFAOYSA-N 0.000 description 5
- IJEZMDPWGDWYKJ-UHFFFAOYSA-N 6-chloro-3-nitroimidazo[1,2-b]pyridazine Chemical compound C1=CC(Cl)=NN2C([N+](=O)[O-])=CN=C21 IJEZMDPWGDWYKJ-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 5
- 239000005864 Sulphur Substances 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 description 3
- JWAWZBZHCLQOHR-UHFFFAOYSA-N 2-[[2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloropyridin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1Cl JWAWZBZHCLQOHR-UHFFFAOYSA-N 0.000 description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 241000590002 Helicobacter pylori Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DPAKHEBMASRRTD-UHFFFAOYSA-N [4-(3-chloropropoxy)-3-methylpyridin-2-yl]methanol Chemical compound CC1=C(OCCCCl)C=CN=C1CO DPAKHEBMASRRTD-UHFFFAOYSA-N 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 229940037467 helicobacter pylori Drugs 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- UEAIOHHGRGSGGJ-UHFFFAOYSA-N (4-chloropyridin-2-yl)methanol Chemical compound OCC1=CC(Cl)=CC=N1 UEAIOHHGRGSGGJ-UHFFFAOYSA-N 0.000 description 2
- PYEMQZVLGRZLJS-UHFFFAOYSA-N 2-[[2-(hydroxymethyl)pyridin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(CO)=C1 PYEMQZVLGRZLJS-UHFFFAOYSA-N 0.000 description 2
- UPROJDCNZYVETO-UHFFFAOYSA-N 2-[[3-chloro-2-(chloromethyl)pyridin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(CCl)=C1Cl UPROJDCNZYVETO-UHFFFAOYSA-N 0.000 description 2
- DCIOIMWRIGTQOP-UHFFFAOYSA-N 2-[[3-chloro-2-(hydroxymethyl)pyridin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(CO)=C1Cl DCIOIMWRIGTQOP-UHFFFAOYSA-N 0.000 description 2
- IHEMNLDSTXKDPL-UHFFFAOYSA-N 3-[2-(hydroxymethyl)-3-methylpyridin-4-yl]oxypropan-1-ol Chemical compound CC1=C(CO)N=CC=C1OCCCO IHEMNLDSTXKDPL-UHFFFAOYSA-N 0.000 description 2
- BEMOQOKAFQXXOM-UHFFFAOYSA-N 3-[[2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloropyridin-4-yl]-methylamino]propan-1-ol Chemical compound OCCCN(C)C1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1Cl BEMOQOKAFQXXOM-UHFFFAOYSA-N 0.000 description 2
- VFTDARXSRHUGIM-UHFFFAOYSA-N 3-[[3-chloro-2-(chloromethyl)pyridin-4-yl]-methylamino]propan-1-ol Chemical compound OCCCN(C)C1=CC=NC(CCl)=C1Cl VFTDARXSRHUGIM-UHFFFAOYSA-N 0.000 description 2
- KTSXIICOIKZGGR-UHFFFAOYSA-N 3-[[3-chloro-2-(hydroxymethyl)pyridin-4-yl]-methylamino]propan-1-ol Chemical compound OCCCN(C)C1=CC=NC(CO)=C1Cl KTSXIICOIKZGGR-UHFFFAOYSA-N 0.000 description 2
- UTXVTZJWDRBHTP-UHFFFAOYSA-N 3-chloro-n-(2-chloroethyl)-2-(chloromethyl)-n-methylpyridin-4-amine Chemical compound ClCCN(C)C1=CC=NC(CCl)=C1Cl UTXVTZJWDRBHTP-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- DKNLQVYVOSJLFS-UHFFFAOYSA-N [3-chloro-4-[2-chloroethyl(methyl)amino]pyridin-2-yl]methanol Chemical compound ClCCN(C)C1=CC=NC(CO)=C1Cl DKNLQVYVOSJLFS-UHFFFAOYSA-N 0.000 description 2
- OAVSWCUZHPOIAY-UHFFFAOYSA-N [3-chloro-4-[2-chloroethyl(methyl)amino]pyridin-2-yl]methyl acetate Chemical compound ClCCN(C)C1=CC=NC(COC(C)=O)=C1Cl OAVSWCUZHPOIAY-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical compound SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- RTWMJHUHCFTRAG-WLHGVMLRSA-N (E)-but-2-enedioic acid 6-[3-[2-(2-methoxyethylsulfanylmethyl)-3-methylpyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine Chemical compound OC(=O)\C=C\C(O)=O.COCCSCC1=NC=CC(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)=C1C RTWMJHUHCFTRAG-WLHGVMLRSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- MOXZSKYLLSPATM-UHFFFAOYSA-N 1-(4-hydroxyphenyl)-2h-tetrazole-5-thione Chemical compound C1=CC(O)=CC=C1N1C(=S)N=NN1 MOXZSKYLLSPATM-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- VSWPGAIWKHPTKX-UHFFFAOYSA-N 1-methyl-10-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-thieno[3,4-b][1,5]benzodiazepin-4-one Chemical compound C1CN(C)CCN1CC(=O)N1C2=CC=CC=C2NC(=O)C2=CSC(C)=C21 VSWPGAIWKHPTKX-UHFFFAOYSA-N 0.000 description 1
- FHTDDANQIMVWKZ-UHFFFAOYSA-N 1h-pyridine-4-thione Chemical compound SC1=CC=NC=C1 FHTDDANQIMVWKZ-UHFFFAOYSA-N 0.000 description 1
- 125000004825 2,2-dimethylpropylene group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[*:1])C([H])([H])[*:2] 0.000 description 1
- YFKBLAQGWRGHKO-UHFFFAOYSA-N 2-(1H-benzimidazol-2-ylsulfanylmethyl)-3-chloro-N-(2-chloroethyl)-N-methylpyridin-4-amine dihydrochloride Chemical compound Cl.Cl.ClCCN(C)C1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1Cl YFKBLAQGWRGHKO-UHFFFAOYSA-N 0.000 description 1
- DJDPXQDDUNEASR-UHFFFAOYSA-N 2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloro-n-(2-chloroethyl)-n-methylpyridin-4-amine Chemical compound ClCCN(C)C1=CC=NC(CSC=2NC3=CC=CC=C3N=2)=C1Cl DJDPXQDDUNEASR-UHFFFAOYSA-N 0.000 description 1
- ZTRHCXRPGWFUPP-UHFFFAOYSA-N 2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloro-n-methyl-n-[2-(3-nitroimidazo[1,2-b]pyridazin-6-yl)oxyethyl]pyridin-4-amine;hydrochloride Chemical compound Cl.C1=CC=C2NC(SCC=3N=CC=C(C=3Cl)N(CCOC3=NN4C([N+]([O-])=O)=CN=C4C=C3)C)=NC2=C1 ZTRHCXRPGWFUPP-UHFFFAOYSA-N 0.000 description 1
- OEIWCCCQFFNLOD-UHFFFAOYSA-N 2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloro-n-methyl-n-[3-(3-nitroimidazo[1,2-b]pyridazin-6-yl)oxypropyl]pyridin-4-amine;hydrochloride Chemical compound Cl.C1=CC=C2NC(SCC=3N=CC=C(C=3Cl)N(CCCOC3=NN4C([N+]([O-])=O)=CN=C4C=C3)C)=NC2=C1 OEIWCCCQFFNLOD-UHFFFAOYSA-N 0.000 description 1
- YGTUPRIZNBMOFV-UHFFFAOYSA-N 2-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)C1=CC=C(O)C=C1 YGTUPRIZNBMOFV-UHFFFAOYSA-N 0.000 description 1
- XAZPURCRJDKOKU-UHFFFAOYSA-N 2-(chloromethyl)-4-(3-chloropropoxy)-3-methylpyridine Chemical compound CC1=C(CCl)N=CC=C1OCCCCl XAZPURCRJDKOKU-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- UECOIZXRGLJBPF-UHFFFAOYSA-N 2-[2-[[3-methyl-4-[3-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylpropylsulfanyl]pyridin-2-yl]methylsulfanyl]-3h-benzimidazol-5-yl]-1,3-thiazole;hydrochloride Chemical compound Cl.CC1=C(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)C=CN=C1CSC(NC1=C2)=NC1=CC=C2C1=NC=CS1 UECOIZXRGLJBPF-UHFFFAOYSA-N 0.000 description 1
- ICTVDIFHNKXSEU-UHFFFAOYSA-N 2-[[3-methyl-4-[3-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylpropylsulfanyl]pyridin-2-yl]methylsulfanyl]pyrimidine-4,6-diamine;hydrochloride Chemical compound Cl.CC1=C(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)C=CN=C1CSC1=NC(N)=CC(N)=N1 ICTVDIFHNKXSEU-UHFFFAOYSA-N 0.000 description 1
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004838 2-methylpentylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- KRGXWTOLFOPIKV-UHFFFAOYSA-N 3-(methylamino)propan-1-ol Chemical compound CNCCCO KRGXWTOLFOPIKV-UHFFFAOYSA-N 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- TWJTYOQMIRLYMJ-UHFFFAOYSA-N 3-chloro-n-(2-chloroethyl)-2-(chloromethyl)-n-methylpyridin-4-amine;hydrochloride Chemical compound Cl.ClCCN(C)C1=CC=NC(CCl)=C1Cl TWJTYOQMIRLYMJ-UHFFFAOYSA-N 0.000 description 1
- 125000004820 3-methylbutylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- OQOGNLBKSHSUMN-UHFFFAOYSA-N 3-nitro-6-tritylsulfanylimidazo[1,2-b]pyridazine Chemical compound N=1N2C([N+](=O)[O-])=CN=C2C=CC=1SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 OQOGNLBKSHSUMN-UHFFFAOYSA-N 0.000 description 1
- YWTZZJSJUVSJKG-UHFFFAOYSA-N 3-nitroimidazo[1,2-b]pyridazine Chemical compound C1=CC=NN2C([N+](=O)[O-])=CN=C21 YWTZZJSJUVSJKG-UHFFFAOYSA-N 0.000 description 1
- LSCOMGFYEWVYJG-UHFFFAOYSA-N 3-pyridin-2-yl-1h-imidazole-2-thione Chemical compound S=C1NC=CN1C1=CC=CC=N1 LSCOMGFYEWVYJG-UHFFFAOYSA-N 0.000 description 1
- QCAWOHUJKPKOMD-UHFFFAOYSA-N 4,6-diamino-1h-pyrimidine-2-thione Chemical compound NC1=CC(N)=NC(S)=N1 QCAWOHUJKPKOMD-UHFFFAOYSA-N 0.000 description 1
- RAFAYWADRVMWFA-UHFFFAOYSA-N 4,6-dimethyl-1h-pyrimidine-2-thione Chemical compound CC1=CC(C)=NC(S)=N1 RAFAYWADRVMWFA-UHFFFAOYSA-N 0.000 description 1
- MCUYHRNUDDANSO-UHFFFAOYSA-N 4-chloro-2,3-dimethyl-1-oxidopyridin-1-ium Chemical compound CC1=C(C)[N+]([O-])=CC=C1Cl MCUYHRNUDDANSO-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- NHHLLXDWPQNCHU-UHFFFAOYSA-N 5-(1,3-thiazol-2-yl)-1,3-dihydrobenzimidazole-2-thione Chemical compound C1=C2NC(=S)NC2=CC=C1C1=NC=CS1 NHHLLXDWPQNCHU-UHFFFAOYSA-N 0.000 description 1
- ZNNNEAZGZYEQFW-UHFFFAOYSA-N 5-methylsulfanyl-1,3-dihydrobenzimidazole-2-thione Chemical compound CSC1=CC=C2NC(=S)NC2=C1 ZNNNEAZGZYEQFW-UHFFFAOYSA-N 0.000 description 1
- LYPXFQZEUZZLOT-UHFFFAOYSA-N 5-methylsulfonyl-1,3-dihydrobenzimidazole-2-thione Chemical compound CS(=O)(=O)C1=CC=C2NC(=S)NC2=C1 LYPXFQZEUZZLOT-UHFFFAOYSA-N 0.000 description 1
- XLWPBRBWVIDAMT-UHFFFAOYSA-N 6-[3-[2-(methoxymethyl)-3-methylpyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine Chemical compound COCC1=NC=CC(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)=C1C XLWPBRBWVIDAMT-UHFFFAOYSA-N 0.000 description 1
- GNGJEBQTIQVACL-UHFFFAOYSA-N 6-[3-[2-[(4,6-dimethylpyrimidin-2-yl)sulfanylmethyl]-3-methylpyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine Chemical compound CC1=CC(C)=NC(SCC=2C(=C(SCCCSC3=NN4C([N+]([O-])=O)=CN=C4C=C3)C=CN=2)C)=N1 GNGJEBQTIQVACL-UHFFFAOYSA-N 0.000 description 1
- AFLWSIJDUPKREV-UHFFFAOYSA-N 6-[3-[3-methyl-2-[(1-phenyltetrazol-5-yl)sulfanylmethyl]pyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine;hydrochloride Chemical compound Cl.CC1=C(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)C=CN=C1CSC1=NN=NN1C1=CC=CC=C1 AFLWSIJDUPKREV-UHFFFAOYSA-N 0.000 description 1
- JNSVSKWPGBNIJQ-UHFFFAOYSA-N 6-[3-[3-methyl-2-[(1-pyridin-2-ylimidazol-2-yl)sulfanylmethyl]pyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine Chemical compound CC1=C(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)C=CN=C1CSC1=NC=CN1C1=CC=CC=N1 JNSVSKWPGBNIJQ-UHFFFAOYSA-N 0.000 description 1
- VNTQULZHLIPZMA-UHFFFAOYSA-N 6-[3-[3-methyl-2-[(6-methylsulfanyl-1h-benzimidazol-2-yl)sulfanylmethyl]pyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine;hydrochloride Chemical compound Cl.C1=CC2=NC=C([N+]([O-])=O)N2N=C1SCCCSC1=C(C)C(CSC2=NC3=CC=C(C=C3N2)SC)=NC=C1 VNTQULZHLIPZMA-UHFFFAOYSA-N 0.000 description 1
- LGOOKKLICFYXLD-UHFFFAOYSA-N 6-[3-[3-methyl-2-[[1-(3-methylpyridin-2-yl)imidazol-2-yl]sulfanylmethyl]pyridin-4-yl]sulfanylpropylsulfanyl]-3-nitroimidazo[1,2-b]pyridazine;hydrochloride Chemical compound Cl.CC1=CC=CN=C1N1C(SCC=2C(=C(SCCCSC3=NN4C([N+]([O-])=O)=CN=C4C=C3)C=CN=2)C)=NC=C1 LGOOKKLICFYXLD-UHFFFAOYSA-N 0.000 description 1
- BWYGMIYEADAIGW-UHFFFAOYSA-N 6-amino-2-sulfanylidene-1h-pyrimidin-4-one;hydrate Chemical compound O.NC1=CC(=O)NC(=S)N1 BWYGMIYEADAIGW-UHFFFAOYSA-N 0.000 description 1
- UQJLPBLXSJWAKG-UHFFFAOYSA-N 6-methyl-1h-pyrimidin-3-ium-2-thione;chloride Chemical compound Cl.CC1=CC=NC(=S)N1 UQJLPBLXSJWAKG-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000590017 Helicobacter felis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
- CBRGQZWFCKPHCF-UHFFFAOYSA-N [3-chloro-4-[(2-chloroethylamino)methyl]pyridin-2-yl]-pyrimidin-2-ylmethanethiol;hydrochloride Chemical compound Cl.N=1C=CC(CNCCCl)=C(Cl)C=1C(S)C1=NC=CC=N1 CBRGQZWFCKPHCF-UHFFFAOYSA-N 0.000 description 1
- JGPPTBSHKLLINU-UHFFFAOYSA-N [3-chloro-4-[methyl-[2-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylethyl]amino]pyridin-2-yl]methanol Chemical compound C1=CC2=NC=C([N+]([O-])=O)N2N=C1SCCN(C)C1=CC=NC(CO)=C1Cl JGPPTBSHKLLINU-UHFFFAOYSA-N 0.000 description 1
- PFHRHBWLJONOMY-UHFFFAOYSA-N [3-methyl-4-(3-sulfanylpropylsulfanyl)pyridin-2-yl]methanol Chemical compound CC1=C(SCCCS)C=CN=C1CO PFHRHBWLJONOMY-UHFFFAOYSA-N 0.000 description 1
- OIAQIDHOHSFFLX-UHFFFAOYSA-N [3-methyl-4-[3-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylpropoxy]pyridin-2-yl]methanol Chemical compound C1=CN=C(CO)C(C)=C1OCCCSC1=NN2C([N+]([O-])=O)=CN=C2C=C1 OIAQIDHOHSFFLX-UHFFFAOYSA-N 0.000 description 1
- XTSSGYDMIVOBLH-UHFFFAOYSA-N [4-(3-chloropropoxy)-3-methylpyridin-2-yl]methyl acetate Chemical compound CC(=O)OCC1=NC=CC(OCCCCl)=C1C XTSSGYDMIVOBLH-UHFFFAOYSA-N 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000362 adenosine triphosphatase inhibitor Substances 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- JIFPTBLGXRKRAO-UHFFFAOYSA-K aluminum;magnesium;hydroxide;sulfate Chemical compound [OH-].[Mg+2].[Al+3].[O-]S([O-])(=O)=O JIFPTBLGXRKRAO-UHFFFAOYSA-K 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000007382 columbia agar Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- SIXIIKVOZAGHPV-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=C[CH]C2=N1 SIXIIKVOZAGHPV-UHFFFAOYSA-N 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- 229960004018 magaldrate Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- VEZDAWXAFNOXDO-UHFFFAOYSA-N n-[[2-(1h-benzimidazol-2-ylsulfanylmethyl)-3-chloropyridin-4-yl]methyl]-2-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylethanamine Chemical compound C1=CC=C2NC(SCC=3N=CC=C(C=3Cl)CNCCSC=3C=CC4=NC=C(N4N=3)[N+](=O)[O-])=NC2=C1 VEZDAWXAFNOXDO-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 1
- 229960000564 nitrofurantoin Drugs 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 229960005019 pantoprazole Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- RMHMFHUVIITRHF-UHFFFAOYSA-N pirenzepine Chemical compound C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 RMHMFHUVIITRHF-UHFFFAOYSA-N 0.000 description 1
- 229960004633 pirenzepine Drugs 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- ZJLMKPKYJBQJNH-UHFFFAOYSA-N propane-1,3-dithiol Chemical compound SCCCS ZJLMKPKYJBQJNH-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RYVMUASDIZQXAA-UHFFFAOYSA-N pyranoside Natural products O1C2(OCC(C)C(OC3C(C(O)C(O)C(CO)O3)O)C2)C(C)C(C2(CCC3C4(C)CC5O)C)C1CC2C3CC=C4CC5OC(C(C1O)O)OC(CO)C1OC(C1OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OCC(O)C(O)C1O RYVMUASDIZQXAA-UHFFFAOYSA-N 0.000 description 1
- WFJZBOIOPMOUCB-UHFFFAOYSA-N pyridazine;hydrochloride Chemical compound Cl.C1=CC=NN=C1 WFJZBOIOPMOUCB-UHFFFAOYSA-N 0.000 description 1
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- KFHJGCJNALDXEB-UHFFFAOYSA-N s-[[3-methyl-4-[3-(3-nitroimidazo[1,2-b]pyridazin-6-yl)sulfanylpropylsulfanyl]pyridin-2-yl]methyl] ethanethioate Chemical compound CC(=O)SCC1=NC=CC(SCCCSC2=NN3C([N+]([O-])=O)=CN=C3C=C2)=C1C KFHJGCJNALDXEB-UHFFFAOYSA-N 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229950004351 telenzepine Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229960005053 tinidazole Drugs 0.000 description 1
- JQZIKLPHXXBMCA-UHFFFAOYSA-N triphenylmethanethiol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(S)C1=CC=CC=C1 JQZIKLPHXXBMCA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Paper (AREA)
- Cosmetics (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19653375 | 1996-12-20 | ||
| EP97101668 | 1997-02-04 | ||
| PCT/EP1997/007133 WO1998028299A2 (en) | 1996-12-20 | 1997-12-18 | Imidazopyridazines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993050D0 NO993050D0 (no) | 1999-06-21 |
| NO993050L NO993050L (no) | 1999-06-21 |
| NO312729B1 true NO312729B1 (no) | 2002-06-24 |
Family
ID=26032538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993050A NO312729B1 (no) | 1996-12-20 | 1999-06-21 | Imidazopyridaziner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6043242A (ja) |
| EP (1) | EP0946559A2 (ja) |
| JP (1) | JP2001506666A (ja) |
| KR (1) | KR20000057649A (ja) |
| CN (1) | CN1105720C (ja) |
| AU (1) | AU733552B2 (ja) |
| BR (1) | BR9714049A (ja) |
| CA (1) | CA2275601A1 (ja) |
| EA (1) | EA001734B1 (ja) |
| EE (1) | EE03690B1 (ja) |
| HU (1) | HUP0000460A3 (ja) |
| IL (1) | IL130348A (ja) |
| NO (1) | NO312729B1 (ja) |
| NZ (1) | NZ336034A (ja) |
| PL (1) | PL334194A1 (ja) |
| SK (1) | SK81299A3 (ja) |
| TR (1) | TR199901386T2 (ja) |
| UA (1) | UA57056C2 (ja) |
| WO (1) | WO1998028299A2 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2362930C (en) * | 1999-02-26 | 2010-10-05 | Nitromed, Inc. | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
| US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
| CN1386202A (zh) * | 2000-05-31 | 2002-12-18 | 三井化学株式会社 | 利用芳族硫醚化合物的光学材料和光学部件以及芳族硫醚化合物 |
| AR035966A1 (es) | 2001-05-18 | 2004-07-28 | Altana Pharma Ag | Un compuesto de bencilaminopirimidina, un medicamento que lo comprende y el uso del mismo |
| EP1796673A2 (en) * | 2004-09-23 | 2007-06-20 | Reddy US Therapeutics, Inc. | Novel pyrimidine compounds, process for their preparation and compositions containing them |
| KR20080076924A (ko) | 2005-12-05 | 2008-08-20 | 아스트라제네카 아베 | 에소메프라졸 비-염 형태의 제조를 위한 신규 방법 |
| TW201100411A (en) | 2009-05-21 | 2011-01-01 | Chlorion Pharma Inc | Pyrimidines as novel therapeutic agents |
| CN108129703A (zh) * | 2017-11-13 | 2018-06-08 | 孝感市锐思新材科技有限公司 | 一种塑料抗菌材料的制备方法 |
| CN108047216B (zh) * | 2017-12-06 | 2020-11-10 | 石家庄学院 | 一种3,4-二苯基吡唑化合物及其制备和应用 |
| CN111226956B (zh) * | 2019-11-26 | 2021-10-26 | 贵州医科大学 | 3,6-二取代咪唑[1,2-b]哒嗪类衍生物在制备抑制植物病原真菌杀菌剂中的应用 |
| US11993580B1 (en) | 2022-12-02 | 2024-05-28 | Neumora Therapeutics, Inc. | Methods of treating neurological disorders |
| WO2024185814A1 (ja) * | 2023-03-06 | 2024-09-12 | Ａｇｃ株式会社 | トリチルスルファニル基含有アリール化合物の製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4569932A (en) * | 1982-11-12 | 1986-02-11 | University Of Northern Iowa Foundations | Low toxicity radiation sensitizer |
| US4569934A (en) * | 1984-10-09 | 1986-02-11 | American Cyanamid Company | Imidazo[1,2-b]pyridazines |
| PH27291A (en) * | 1989-01-31 | 1993-05-04 | Takeda Chemical Industries Ltd | Imidazolpyrimidazines their production and use |
| JPH0717971A (ja) * | 1993-07-02 | 1995-01-20 | Takeda Chem Ind Ltd | イミダゾール誘導体、その製造法及び用途 |
| JPH0820584A (ja) * | 1994-07-04 | 1996-01-23 | Takeda Chem Ind Ltd | イミダゾール誘導体及びその用途 |
-
1997
- 1997-12-18 AU AU58579/98A patent/AU733552B2/en not_active Ceased
- 1997-12-18 BR BR9714049-0A patent/BR9714049A/pt not_active IP Right Cessation
- 1997-12-18 PL PL97334194A patent/PL334194A1/xx unknown
- 1997-12-18 EP EP97954426A patent/EP0946559A2/en not_active Withdrawn
- 1997-12-18 TR TR1999/01386T patent/TR199901386T2/xx unknown
- 1997-12-18 JP JP52836098A patent/JP2001506666A/ja active Pending
- 1997-12-18 IL IL13034897A patent/IL130348A/xx active IP Right Grant
- 1997-12-18 HU HU0000460A patent/HUP0000460A3/hu unknown
- 1997-12-18 US US09/319,937 patent/US6043242A/en not_active Expired - Fee Related
- 1997-12-18 KR KR1019990705454A patent/KR20000057649A/ko not_active Application Discontinuation
- 1997-12-18 UA UA99074154A patent/UA57056C2/uk unknown
- 1997-12-18 CN CN97181815A patent/CN1105720C/zh not_active Expired - Fee Related
- 1997-12-18 EA EA199900534A patent/EA001734B1/ru not_active IP Right Cessation
- 1997-12-18 EE EEP199900234A patent/EE03690B1/xx not_active IP Right Cessation
- 1997-12-18 NZ NZ336034A patent/NZ336034A/xx unknown
- 1997-12-18 CA CA002275601A patent/CA2275601A1/en not_active Abandoned
- 1997-12-18 WO PCT/EP1997/007133 patent/WO1998028299A2/en not_active Application Discontinuation
- 1997-12-18 SK SK812-99A patent/SK81299A3/sk unknown
-
1999
- 1999-06-21 NO NO19993050A patent/NO312729B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA001734B1 (ru) | 2001-08-27 |
| HUP0000460A2 (hu) | 2001-02-28 |
| AU5857998A (en) | 1998-07-17 |
| CA2275601A1 (en) | 1998-07-02 |
| NO993050D0 (no) | 1999-06-21 |
| TR199901386T2 (en) | 1999-09-21 |
| EP0946559A2 (en) | 1999-10-06 |
| JP2001506666A (ja) | 2001-05-22 |
| KR20000057649A (ko) | 2000-09-25 |
| NO993050L (no) | 1999-06-21 |
| EE9900234A (et) | 1999-12-15 |
| WO1998028299A2 (en) | 1998-07-02 |
| PL334194A1 (en) | 2000-02-14 |
| WO1998028299A3 (en) | 1998-08-13 |
| HUP0000460A3 (en) | 2001-04-28 |
| CN1105720C (zh) | 2003-04-16 |
| EE03690B1 (et) | 2002-04-15 |
| NZ336034A (en) | 2000-09-29 |
| UA57056C2 (uk) | 2003-06-16 |
| IL130348A0 (en) | 2000-06-01 |
| CN1246120A (zh) | 2000-03-01 |
| IL130348A (en) | 2003-06-24 |
| US6043242A (en) | 2000-03-28 |
| EA199900534A1 (ru) | 2000-02-28 |
| AU733552B2 (en) | 2001-05-17 |
| BR9714049A (pt) | 2000-05-09 |
| SK81299A3 (en) | 2000-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008277628B2 (en) | Bicyclic heteroaryl compounds and their use as kinase inhibitors | |
| EP2727910B1 (en) | Pyridin-2-yl-thiourea and Pyridin-2-yl-amine derivatives as intermediates for the preparation of Pyridin-2yl-amino-1,2,4-thiadiazole glucokinase activators | |
| CZ20012635A3 (cs) | Aromatické heterocyklické sloučeniny, způsob jejich výroby a jejich pouľití | |
| NO312729B1 (no) | Imidazopyridaziner | |
| US5859030A (en) | Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria | |
| AU702609B2 (en) | Pyridylthio compounds for controlling helicobacter bacteria | |
| DE69922655T2 (de) | Pyrimidin-Aminomethyl-Pyridin Derivate; deren Herstellung und deren Verwendung gegen Helicobacter Bakterien | |
| AU760769B2 (en) | Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity | |
| US6107312A (en) | Thiopyridines for use in the control of helicobacter bacteria | |
| US5922720A (en) | Piperazinothiopyridines for the control of Helicobacter bacteria | |
| US20040158066A1 (en) | Novel pyridylmethylaminopyrimidines | |
| PL178477B1 (pl) | Nowe związki, pochodne arylotioalkilotiopirydyny, oraz sposób ich wytwarzania i lek zawierający te związki | |
| MXPA99005858A (en) | Imidazopyridazines | |
| AU2002314064A1 (en) | Novel pyridylmethylaminopyrimidines |